Your browser doesn't support javascript.
loading
IFITM3 blocks influenza virus entry by sorting lipids and stabilizing hemifusion.
Klein, Steffen; Golani, Gonen; Lolicato, Fabio; Lahr, Carmen; Beyer, Daniel; Herrmann, Alexia; Wachsmuth-Melm, Moritz; Reddmann, Nina; Brecht, Romy; Hosseinzadeh, Mehdi; Kolovou, Androniki; Makroczyova, Jana; Peterl, Sarah; Schorb, Martin; Schwab, Yannick; Brügger, Britta; Nickel, Walter; Schwarz, Ulrich S; Chlanda, Petr.
Afiliação
  • Klein S; Schaller Research Group, Department of Infectious Diseases, Virology, Heidelberg University Hospital, 69120 Heidelberg, Germany; BioQuant Center for Quantitative Biology, Heidelberg University, 69120 Heidelberg, Germany.
  • Golani G; BioQuant Center for Quantitative Biology, Heidelberg University, 69120 Heidelberg, Germany; Institute for Theoretical Physics, Heidelberg University, 69120 Heidelberg, Germany.
  • Lolicato F; Heidelberg University Biochemistry Center, Heidelberg University, 69120 Heidelberg, Germany; Department of Physics, University of Helsinki, Helsinki, Finland.
  • Lahr C; Schaller Research Group, Department of Infectious Diseases, Virology, Heidelberg University Hospital, 69120 Heidelberg, Germany; BioQuant Center for Quantitative Biology, Heidelberg University, 69120 Heidelberg, Germany.
  • Beyer D; Heidelberg University Biochemistry Center, Heidelberg University, 69120 Heidelberg, Germany.
  • Herrmann A; Heidelberg University Biochemistry Center, Heidelberg University, 69120 Heidelberg, Germany.
  • Wachsmuth-Melm M; Schaller Research Group, Department of Infectious Diseases, Virology, Heidelberg University Hospital, 69120 Heidelberg, Germany; BioQuant Center for Quantitative Biology, Heidelberg University, 69120 Heidelberg, Germany.
  • Reddmann N; Schaller Research Group, Department of Infectious Diseases, Virology, Heidelberg University Hospital, 69120 Heidelberg, Germany; BioQuant Center for Quantitative Biology, Heidelberg University, 69120 Heidelberg, Germany.
  • Brecht R; Schaller Research Group, Department of Infectious Diseases, Virology, Heidelberg University Hospital, 69120 Heidelberg, Germany; BioQuant Center for Quantitative Biology, Heidelberg University, 69120 Heidelberg, Germany.
  • Hosseinzadeh M; Schaller Research Group, Department of Infectious Diseases, Virology, Heidelberg University Hospital, 69120 Heidelberg, Germany; BioQuant Center for Quantitative Biology, Heidelberg University, 69120 Heidelberg, Germany.
  • Kolovou A; Schaller Research Group, Department of Infectious Diseases, Virology, Heidelberg University Hospital, 69120 Heidelberg, Germany; BioQuant Center for Quantitative Biology, Heidelberg University, 69120 Heidelberg, Germany.
  • Makroczyova J; Schaller Research Group, Department of Infectious Diseases, Virology, Heidelberg University Hospital, 69120 Heidelberg, Germany; BioQuant Center for Quantitative Biology, Heidelberg University, 69120 Heidelberg, Germany.
  • Peterl S; Schaller Research Group, Department of Infectious Diseases, Virology, Heidelberg University Hospital, 69120 Heidelberg, Germany; BioQuant Center for Quantitative Biology, Heidelberg University, 69120 Heidelberg, Germany.
  • Schorb M; Electron Microscopy Core Facility, European Molecular Biology Laboratory, 69117 Heidelberg, Germany.
  • Schwab Y; Electron Microscopy Core Facility, European Molecular Biology Laboratory, 69117 Heidelberg, Germany.
  • Brügger B; Heidelberg University Biochemistry Center, Heidelberg University, 69120 Heidelberg, Germany.
  • Nickel W; Heidelberg University Biochemistry Center, Heidelberg University, 69120 Heidelberg, Germany.
  • Schwarz US; BioQuant Center for Quantitative Biology, Heidelberg University, 69120 Heidelberg, Germany; Institute for Theoretical Physics, Heidelberg University, 69120 Heidelberg, Germany.
  • Chlanda P; Schaller Research Group, Department of Infectious Diseases, Virology, Heidelberg University Hospital, 69120 Heidelberg, Germany; BioQuant Center for Quantitative Biology, Heidelberg University, 69120 Heidelberg, Germany. Electronic address: petr.chlanda@bioquant.uni-heidelberg.de.
Cell Host Microbe ; 31(4): 616-633.e20, 2023 04 12.
Article em En | MEDLINE | ID: mdl-37003257
Interferon-induced transmembrane protein 3 (IFITM3) inhibits the entry of numerous viruses through undefined molecular mechanisms. IFITM3 localizes in the endosomal-lysosomal system and specifically affects virus fusion with target cell membranes. We found that IFITM3 induces local lipid sorting, resulting in an increased concentration of lipids disfavoring viral fusion at the hemifusion site. This increases the energy barrier for fusion pore formation and the hemifusion dwell time, promoting viral degradation in lysosomes. In situ cryo-electron tomography captured IFITM3-mediated arrest of influenza A virus membrane fusion. Observation of hemifusion diaphragms between viral particles and late endosomal membranes confirmed hemifusion stabilization as a molecular mechanism of IFITM3. The presence of the influenza fusion protein hemagglutinin in post-fusion conformation close to hemifusion sites further indicated that IFITM3 does not interfere with the viral fusion machinery. Collectively, these findings show that IFITM3 induces lipid sorting to stabilize hemifusion and prevent virus entry into target cells.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus da Influenza A / Influenza Humana Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cell Host Microbe Assunto da revista: MICROBIOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus da Influenza A / Influenza Humana Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cell Host Microbe Assunto da revista: MICROBIOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha